Paul Kwon
Equibles does not estimate personal net worth.
Get an email with a short summary when Yarrow Bioscience, Inc. publishes a filing, an earnings call transcript or a press release.
Get YARW alertsAbout Paul Kwon
The proxy statement of Yarrow Bioscience, Inc. reports total compensation of $892,888 for Paul Kwon in fiscal 2019, including a base salary of $412,000. Yarrow Bioscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Yarrow Bioscience, Inc. includes Rebecca Frey (CEO and Board Member), Bill Lundberg (Chairman and Board Member), Andrew Saik (CFO) and 7 others.
Affiliation history
-
Yarrow Bioscience, Inc. (YARW)
Proxy statement
Current
Company network
Leadership on record at Yarrow Bioscience, Inc.
- Rebecca Frey CEO, Board Member
- Bill Lundberg Chairman, Board Member
- Andrew Saik CFO
- Ilan Hadar CFO
- Tyler Zeronda CFO
- Rachael Alford COO
- Iain Stuart CTO
- David Domzalski Board Member
- Dr. Christine Borowski Board Member
- Mona Ashiya Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Yarrow Bioscience, Inc. (YARW) | Former Chief Scientific Officer | $412,000 | $892,888 |
Recent activity
No call appearances or filed executive changes recorded yet.